• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三维肿瘤体积和血清甲胎蛋白是肝移植后肝细胞癌复发的预测指标:优化的选择标准。

Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteria.

作者信息

Kashkoush Samy, El Moghazy Walid, Kawahara Toshiyasu, Gala-Lopez Boris, Toso Christian, Kneteman Norman M

机构信息

Division of Transplantation, Department of Surgery, University of Alberta, Edmonton, AB, Canada; Department of Surgery, National Liver Institute, Menofiya University, Menofiya, Egypt.

出版信息

Clin Transplant. 2014 Jun;28(6):728-36. doi: 10.1111/ctr.12373. Epub 2014 May 10.

DOI:10.1111/ctr.12373
PMID:24708263
Abstract

Total tumor volume (TTV), as a better predictor of hepatocellular carcinoma (HCC) recurrence after liver transplant, has been explored by our center. Some tumors are not typically spherical but rather ellipsoid or spheroid, and calculating their TTV based on one dimension only may overestimate their volume and exclude them from candidacy for transplantation. Our aim was to study the actual tumor volume (ATV) calculated using the ellipsoid formula and assess its impact on recurrence. HCC patients transplanted between 1990 and 2010 at University of Alberta Hospital were analyzed. Tumor volumes were calculated using both formulas: [(4/3) πr(3)] (r = max. radius) and [(4/3) πabc] (a, b, c = the 3 radiuses). A total of 115 patients were included with a mean follow-up of 4.99 ± 4.23 yr. Five-yr recurrence-free survival was 79.8%. Univariate analysis for predictors of recurrence included: maximum tumor diameter, ATV, TTV, and alpha-fetoprotein (AFP) ≥ 400 ng/mL. Multivariate analysis showed that ATV and AFP ≥ 400 ng/mL were the only predictors of recurrence. Combining both variables provides better predication of recurrence with accuracy that exceeds 80%. Three-dimensional calculation of tumor volume is of critical importance for the group of patients with ellipsoid tumors where volumes are overestimated with the spherical formula and could lead to inappropriate exclusion from transplant.

摘要

我们中心对总肿瘤体积(TTV)作为肝移植后肝细胞癌(HCC)复发的更好预测指标进行了探索。一些肿瘤并非典型的球形,而是椭圆形或类球形,仅基于一个维度计算其TTV可能会高估其体积,并将它们排除在移植候选范围之外。我们的目的是研究使用椭球体公式计算的实际肿瘤体积(ATV),并评估其对复发的影响。对1990年至2010年间在阿尔伯塔大学医院接受移植的HCC患者进行了分析。使用两种公式计算肿瘤体积:[(4/3)πr(3)](r =最大半径)和[(4/3)πabc](a、b、c =三个半径)。共纳入115例患者,平均随访4.99±4.23年。5年无复发生存率为79.8%。复发预测因素的单变量分析包括:最大肿瘤直径、ATV、TTV和甲胎蛋白(AFP)≥400 ng/mL。多变量分析显示,ATV和AFP≥400 ng/mL是复发的唯一预测因素。将这两个变量结合起来能更好地预测复发,准确率超过80%。对于椭圆形肿瘤患者群体,肿瘤体积的三维计算至关重要,因为球形公式会高估其体积,可能导致不恰当地将其排除在移植范围之外。

相似文献

1
Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteria.三维肿瘤体积和血清甲胎蛋白是肝移植后肝细胞癌复发的预测指标:优化的选择标准。
Clin Transplant. 2014 Jun;28(6):728-36. doi: 10.1111/ctr.12373. Epub 2014 May 10.
2
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.一种新型预后列线图可准确预测肝移植后肝细胞癌复发:对865例连续肝移植受者的分析
J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.
3
Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.肿瘤生长速率可预测超出米兰或加州大学旧金山分校标准的患者肝移植后肝细胞癌的复发情况。
Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.
4
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.肝癌肝移植:包含甲胎蛋白的模型可改善米兰标准的性能。
Gastroenterology. 2012 Oct;143(4):986-94.e3; quiz e14-5. doi: 10.1053/j.gastro.2012.05.052. Epub 2012 Jun 29.
5
A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.一种利用血清甲胎蛋白水平的修订评分系统,以扩大肝细胞癌活体供体移植的候选者范围。
Surgery. 2007 May;141(5):598-609. doi: 10.1016/j.surg.2006.11.006. Epub 2007 Mar 23.
6
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.总肿瘤体积和甲胎蛋白联合用于选择肝癌肝移植候选者:前瞻性验证。
Hepatology. 2015 Jul;62(1):158-65. doi: 10.1002/hep.27787. Epub 2015 Apr 22.
7
Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer.评估总肿瘤体积和移植前甲胎蛋白水平作为肝细胞癌患者肝移植选择标准的情况。
Transplant Proc. 2013 Jun;45(5):1899-903. doi: 10.1016/j.transproceed.2012.12.010.
8
Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.分析原发性根治性切除术后肝癌不可移植复发的危险因素。
Ann Surg Oncol. 2013 Aug;20(8):2526-33. doi: 10.1245/s10434-013-2940-7. Epub 2013 Mar 16.
9
α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.甲胎蛋白是入选肝移植的乙型肝炎相关肝细胞癌患者的潜在生存预测指标。
Eur J Gastroenterol Hepatol. 2014 May;26(5):544-52. doi: 10.1097/MEG.0000000000000029.
10
Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.影响肝细胞癌活体肝移植术后复发及生存的因素。
Hepatogastroenterology. 2013 Nov-Dec;60(128):1847-53.

引用本文的文献

1
A preoperative inflammatory score-based nomogram predicts overall survival after curative hepatectomy for hepatocellular carcinoma.基于术前炎症评分的列线图可预测肝细胞癌根治性肝切除术后的总生存期。
Discov Oncol. 2025 Aug 31;16(1):1659. doi: 10.1007/s12672-025-03406-1.
2
Comparison of quantitative volumetric analysis and linear measurement for predicting the survival of Barcelona Clinic Liver Cancer 0- and A stage hepatocellular carcinoma after radiofrequency ablation.定量容积分析与线性测量在预测巴塞罗那临床肝癌 0 期和 A 期肝癌经射频消融治疗后生存的比较。
Diagn Interv Radiol. 2023 May 31;29(3):450-459. doi: 10.4274/dir.2023.222055. Epub 2023 May 8.
3
Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
利用 MRI 定量肿瘤负荷影像学生物标志物优化巴塞罗那临床肝癌分期系统在局部区域治疗中的应用。
Radiology. 2022 Jul;304(1):228-237. doi: 10.1148/radiol.212426. Epub 2022 Apr 12.
4
Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis.肝癌患者肝移植选择标准的预后作用:网络荟萃分析。
BJS Open. 2022 Jan 6;6(1). doi: 10.1093/bjsopen/zrab130.
5
Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score.肝细胞癌选择系统与肝移植:从巴别塔到理想的综合评分。
Updates Surg. 2021 Oct;73(5):1599-1614. doi: 10.1007/s13304-021-01078-4. Epub 2021 May 18.
6
Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection.一种用于肝细胞癌手术切除后复发的机器学习预后模型的开发与验证
Front Oncol. 2021 Feb 1;10:593741. doi: 10.3389/fonc.2020.593741. eCollection 2020.
7
Risk Factors and Center-Level Variation in Hepatocellular Carcinoma Under-Staging for Liver Transplantation.肝癌肝移植术前分期不足的危险因素及中心层面差异
Liver Transpl. 2020 Aug;26(8):977-988. doi: 10.1002/lt.25787.
8
Timescale of tumor volume of a young breast cancer patient with luminal B subtype: A case report.一名年轻的luminal B亚型乳腺癌患者肿瘤体积的时间尺度:病例报告。
Medicine (Baltimore). 2019 Oct;98(43):e17659. doi: 10.1097/MD.0000000000017659.
9
Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.移植前甲胎蛋白与移植后肝细胞癌复发死亡率相关。
Clin Transplant. 2019 Jul;33(7):e13634. doi: 10.1111/ctr.13634. Epub 2019 Jun 25.
10
Differences in Posttransplant Hepatocellular Carcinoma Recurrence by Etiology of Liver Disease.移植后肝细胞癌复发因肝病病因的差异
Liver Transpl. 2019 Mar;25(3):388-398. doi: 10.1002/lt.25363.